Consistent with previous reports, MGMT methylation was a favorable prognostic factor for PFS and OS among patients with glioblastoma who underwent 6-week CCRT followed by TMZ; its prognostic significance was also valid in a subgroup of patients who underwent non-GTR. Here, MGMT is linked to glioblastoma.